Comparison of the Effects of Crystalloid Cardioplegia and HTK Solution for Postoperative Troponin-I and CK-MB Levels After Pediatric Cardiac Surgery
NCT ID: NCT01548872
Last Updated: 2012-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
60 participants
INTERVENTIONAL
2011-12-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Histidine-Tryptophan-Ketoglutarate Solution Versus Blood Cardioplegia in CABG
NCT04203680
Fluid Investigation Colloid vs Crystalloid Reg. Renal Hemodynamics and Function
NCT01729364
Effects of Colloid and Crystalloid on the Microcirculatory Alterations During Off-pump Coronary Artery Bypass Surgery
NCT01713166
A Comparison of Etomidate and Ketamine for Anesthesia Induction in Coronary Artery Bypass Graft Surgery
NCT01386229
Comparison of Blood Cardioplegia and Custodiol
NCT01941459
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
crystalloid cardioplegia solution
After aortic cross clamp 30ml/kg will be administered
crystalloid cardioplegia solution
30 ml/kg bolus in two minutes
HTK solution
After aortic cross clamp 50ml/kg will be administered
HTK solution
50 ml/kg bolus in 2 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HTK solution
50 ml/kg bolus in 2 minutes
crystalloid cardioplegia solution
30 ml/kg bolus in two minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients written informed consent for study participation
Exclusion Criteria
* allergy to study drugs
* unstable blood pressure before cardiac surgery
1 Month
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baskent University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Selim Kuslu
Anesthesiology Resident
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baskent University, Faculty of Medicine
Ankara, Çankaya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KA/11-152
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.